Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Current Leases (2019 - 2025)

BioCorRx (BICX) has disclosed Current Leases for 7 consecutive years, with $43382.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 8.3% to $43382.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43382.0 through Dec 2025, up 8.3% year-over-year, with the annual reading at $43382.0 for FY2025, 8.3% up from the prior year.
  • Current Leases hit $43382.0 in Q4 2025 for BioCorRx, up from $41686.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $146187.0 in Q3 2023 to a low of $38491.0 in Q2 2024.
  • Historically, Current Leases has averaged $95614.2 across 5 years, with a median of $114581.5 in 2021.
  • Biggest five-year swings in Current Leases: skyrocketed 37.92% in 2021 and later crashed 73.14% in 2024.
  • Year by year, Current Leases stood at $119733.0 in 2021, then grew by 12.2% to $134343.0 in 2022, then fell by 8.64% to $122732.0 in 2023, then plummeted by 67.36% to $40057.0 in 2024, then increased by 8.3% to $43382.0 in 2025.
  • Business Quant data shows Current Leases for BICX at $43382.0 in Q4 2025, $41686.0 in Q3 2025, and $41686.0 in Q2 2025.